Metabolism of 2-aminoanthracene by BALB/c and C57BL mammary epithelium in vitro

Aromatic primary amines, activated by P-450-dependent mixed-function oxidases have been shown to be mutagenic and carcinogenic in mammary gland of rodents. In this study, we compared 2-aminoanthracene (2AA) metabolism and inhibition in primary mammary gland cultures of BALB/c and C57BL mice. We soug...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Carcinogenesis (New York) 1985-01, Vol.6 (1), p.53-58
Hauptverfasser: Silva, Marilyn H., Petrakis, N.L., Musker, W.Kenneth, Talcott, Ronald E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Aromatic primary amines, activated by P-450-dependent mixed-function oxidases have been shown to be mutagenic and carcinogenic in mammary gland of rodents. In this study, we compared 2-aminoanthracene (2AA) metabolism and inhibition in primary mammary gland cultures of BALB/c and C57BL mice. We sought to establish whether the rate or extent of metabolism was strain dependent as observed with polycydic aromatic hydrocarbons even though the metabolic process would be different. Cells from either strain of mouse were uninjured by doses of 2AA up to 20 μM but produced polar metabolites of 2AA, some of which apparently formed covalent bonds with cellular macromolecules. In each case, covalent binding was inhibited by alpha-napthoflavone (α-NF), a mixed-function oxidase inhibitor. Any notable strain differences in 2AA metabolism and disposition was not observed. Results indicate that mouse mammary epithelial cells are capable of producing reactive metabolites of 2AA, probably via mixed-function oxidation. Thus, metabolic activation of 2AA in breast tissue may induce mutagenesis in mammary epithelium. The inhibitory effects of α-NF suggest that this compound may be of interest as a potential anticarcinogen for the mammary gland.
ISSN:0143-3334
1460-2180
DOI:10.1093/carcin/6.1.53